The American Journal of Medicine
Volume 122, Issue 3 , Page e11 , March 2009

Endogenous Antioxidants in Stroke

References 

  1. Perlstein TS, Pande RL, Creager MA, et al. Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med. 2008;121:781–788
  2. Leinonen JS, Ahonen JP, Lönnrot K, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke. 2000;31:33–39
  3. Cherubini A, Polidori MC, Bregnocchi M, et al. Antioxidant profile and early outcome in stroke patients. Stroke. 2000;31:2295–2300
  4. Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke. 2004;35:156–158
  5. Shin DH, Moon GJ, Bang OY. Albumin therapy in acute stroke patients. J Neurol. 2007;254:870–878

 Funding: None.

 Conflict of Interest: None.

 Authorship: Author had access to all data and a role in writing the manuscript.

PII: S0002-9343(08)00990-X

doi: 10.1016/j.amjmed.2008.10.006

The American Journal of Medicine
Volume 122, Issue 3 , Page e11 , March 2009

Article Tools